Literature DB >> 27150622

Inhibition of Notch rescues the angiogenic potential impaired by cardiovascular risk factors in epicardial adipose stem cells.

Maria Teresa Bejar1, Raquel Ferrer-Lorente, Esther Peña, Lina Badimon.   

Abstract

The epicardial adipose tissue (EAT) is a reservoir of adipose-derived stem cells (ASCs), with as yet unknown effects on myocardial and coronary arteries homeostasis. The purpose of this study was to investigate the angiogenic function of epicardial ASCs and their regulation by the common cardiovascular risk factors (CVRFs) affecting heart disease. Epicardial fat was obtained from a rodent model with clustering of CVRFs [Zucker diabetic fatty (ZDF)-Lepr(fa)] rats and from their lean control (ZDF-Crl) littermates without CVRFs, ASCs were isolated, and their function was assessed by proliferation and differentiation assays, flow cytometry, gene expression, and in vivo Matrigel angiogenesis analysis. Epicardial ASCs from both groups showed adipogenic and osteogenic differentiation capacity; however, epicardial ASCs from CVRF animals had a lesser ability to form tubular structures in vitro after endothelial differentiation, as well as a reduced angiogenic potential in vivo compared to control animals. Epicardial ASCs from CVRF rats showed up-regulation of the downstream Notch signaling genes Hes7, Hey1, and Heyl compared with control animals. The inhibition of Notch signaling by conditioning epicardial ASCs from CVRF animals with a γ-secretase inhibitor induced a reduction in Hes/Hey gene expression and rescued their angiogenic function in vivo We report for the first time the impact of CVRF burden on the ASCs of EAT and that the defective function is in part caused by increased Notch signaling. Conditioning ASCs by blocking Notch signaling rescues their angiogenic potential.-Bejar, M. T., Ferrer-Lorente, R., Peña, E., Badimon, L. Inhibition of Notch rescues the angiogenic potential impaired by cardiovascular risk factors in epicardial adipose stem cells. © FASEB.

Entities:  

Keywords:  Hes/Hey family; ZDF; angiogenesis; differentiation; epicardial adipose tissue

Mesh:

Substances:

Year:  2016        PMID: 27150622     DOI: 10.1096/fj.201600204R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  4 in total

1.  Allogenic adipose-derived stem cell therapy overcomes ischemia-induced microvessel rarefaction in the myocardium: systems biology study.

Authors:  Gemma Vilahur; Blanca Oñate; Judit Cubedo; Maria Teresa Béjar; Gemma Arderiu; Esther Peña; Laura Casaní; Manuel Gutiérrez; Antoni Capdevila; Guillem Pons-Lladó; Francesc Carreras; Alberto Hidalgo; Lina Badimon
Journal:  Stem Cell Res Ther       Date:  2017-03-09       Impact factor: 6.832

2.  Adipose-derived stem cells contribute to cardiovascular remodeling.

Authors:  Hui Ni; Yiming Zhao; Yongli Ji; Jian Shen; Meixiang Xiang; Yao Xie
Journal:  Aging (Albany NY)       Date:  2019-12-04       Impact factor: 5.682

3.  Stem cells from human cardiac adipose tissue depots show different gene expression and functional capacities.

Authors:  Carmen Lambert; Gemma Arderiu; Maria Teresa Bejar; Javier Crespo; Maribel Baldellou; Oriol Juan-Babot; Lina Badimon
Journal:  Stem Cell Res Ther       Date:  2019-11-29       Impact factor: 6.832

4.  Cardiovascular Risk Factors and Differential Transcriptomic Profile of the Subcutaneous and Visceral Adipose Tissue and Their Resident Stem Cells.

Authors:  Gemma Arderiu; Carmen Lambert; Carlos Ballesta; Fabrizio Moscatiello; Gemma Vilahur; Lina Badimon
Journal:  Cells       Date:  2020-10-03       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.